<DOC>
	<DOCNO>NCT02777619</DOCNO>
	<brief_summary>The purpose study determine pharmacodynamic interaction propofol dexmedetomidine , explore effect dexmedetomidine propofol unconsciousness median effective concentration ( EC50 ) .</brief_summary>
	<brief_title>Pharmacodynamic Interactions Propofol Dexmedetomidine Intravenous Anesthesia</brief_title>
	<detailed_description>64 case randomly divide four group , In group , dexmedetomidine target plasma concentration 0 , 0.4 , 0.6 , 0.8 ng/ml . Dexmedetomidine administer 15 min target control infusion propofol . The propofol infusion start provide target effect-site concentration 1.0ug/ml , increase 0.2ug/ml loss consciousness effect-site concentration target concentration equilibrium .</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1 . Weight:18≦ BMI≦25 2 . Written informed consent patient relatives participate patient . 1 . A previous history intolerance study drug relate compound additive . 2 . Existing significant haematological , endocrine , metabolic gastrointestinal disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Propofol</keyword>
	<keyword>Target-controlled Infusion Intravenous Anesthesia</keyword>
</DOC>